Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8

Anna C. Cunningham, Karen A. Hasty, Jan J. Enghild, Alan E. Mast

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Vascular injury results in the activation of coagulation and the release of proteolytic enzymes from neutrophils and connective-tissue cells, High concentrations of these inflammatory proteinases may destroy blood coagulation proteins, contributing to coagulation and bleeding disorders associated with severe inflammation. Matrix metalloproteinase-8 (MMP-8) is released from neutrophils at sites of inflammation and vascular disease. We have investigated the effect of MMP-8 degradation on the anticoagulant function of tissue factor pathway inhibitor (TFPI) as a potential pathological mechanism contributing to coagulation disorders. MMP-8 cleaves TFPI following Ser174 within the connecting region between the second and third Kunitz domains (kcat/Km ∼ 75 M-1 · s-1) as well as following Lys20 within the NH2-terminal region. MMP-8 cleavage of TFPI decreases the anticoagulant activity of TFPI in factor Xa initiated clotting assays as well as the ability of TFPI to inhibit factor Xa in amidolytic assays. Yet, MMP-8 cleavage does not alter the ability of TFPI to inhibit trypsin. Since the inhibition of both factor Xa and trypsin is mediated by binding to the second Kunitz domain, these results suggest that regions of TFPI other than the second Kunitz domain may directly interact with factor Xa. 125I-factor Xa ligand blots of TFPI fragments generated following MMP-8 degradation were used for probing binding interactions between factor Xa and regions of TFPI, other than the second Kunitz domain. In experiments performed under reducing conditions that disrupt the Kunitz domain structure, 125I-factor Xa binds to the C-terminal fragment of MMP-8-degraded TFPI. This fragment contains portions of TFPI distal to Ser174. which include the third Kunitz domain and the basic C-terminal region. An altered form of TFPI lacking the third Kunitz domain, but containing the C-terminal region, was used to demonstrate that the C-terminal region directly interacts with factor Xa.

Original languageEnglish (US)
Pages (from-to)451-458
Number of pages8
JournalBiochemical Journal
Volume367
Issue number2
DOIs
StatePublished - Oct 15 2002

Fingerprint

Matrix Metalloproteinase 8
Degradation
Factor Xa
Coagulation
Anticoagulants
Trypsin
lipoprotein-associated coagulation inhibitor
Assays
Neutrophils
Peptide Hydrolases
Inflammation
Connective Tissue Cells
Vascular System Injuries
Blood Coagulation
Vascular Diseases
Blood Proteins

Keywords

  • Blood coagulation
  • Neutrophil collagenase
  • Proteolysis

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8. / Cunningham, Anna C.; Hasty, Karen A.; Enghild, Jan J.; Mast, Alan E.

In: Biochemical Journal, Vol. 367, No. 2, 15.10.2002, p. 451-458.

Research output: Contribution to journalArticle

@article{92c9ed87d7cc47f183f402b9415ce285,
title = "Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8",
abstract = "Vascular injury results in the activation of coagulation and the release of proteolytic enzymes from neutrophils and connective-tissue cells, High concentrations of these inflammatory proteinases may destroy blood coagulation proteins, contributing to coagulation and bleeding disorders associated with severe inflammation. Matrix metalloproteinase-8 (MMP-8) is released from neutrophils at sites of inflammation and vascular disease. We have investigated the effect of MMP-8 degradation on the anticoagulant function of tissue factor pathway inhibitor (TFPI) as a potential pathological mechanism contributing to coagulation disorders. MMP-8 cleaves TFPI following Ser174 within the connecting region between the second and third Kunitz domains (kcat/Km ∼ 75 M-1 · s-1) as well as following Lys20 within the NH2-terminal region. MMP-8 cleavage of TFPI decreases the anticoagulant activity of TFPI in factor Xa initiated clotting assays as well as the ability of TFPI to inhibit factor Xa in amidolytic assays. Yet, MMP-8 cleavage does not alter the ability of TFPI to inhibit trypsin. Since the inhibition of both factor Xa and trypsin is mediated by binding to the second Kunitz domain, these results suggest that regions of TFPI other than the second Kunitz domain may directly interact with factor Xa. 125I-factor Xa ligand blots of TFPI fragments generated following MMP-8 degradation were used for probing binding interactions between factor Xa and regions of TFPI, other than the second Kunitz domain. In experiments performed under reducing conditions that disrupt the Kunitz domain structure, 125I-factor Xa binds to the C-terminal fragment of MMP-8-degraded TFPI. This fragment contains portions of TFPI distal to Ser174. which include the third Kunitz domain and the basic C-terminal region. An altered form of TFPI lacking the third Kunitz domain, but containing the C-terminal region, was used to demonstrate that the C-terminal region directly interacts with factor Xa.",
keywords = "Blood coagulation, Neutrophil collagenase, Proteolysis",
author = "Cunningham, {Anna C.} and Hasty, {Karen A.} and Enghild, {Jan J.} and Mast, {Alan E.}",
year = "2002",
month = "10",
day = "15",
doi = "10.1042/BJ20020696",
language = "English (US)",
volume = "367",
pages = "451--458",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "2",

}

TY - JOUR

T1 - Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8

AU - Cunningham, Anna C.

AU - Hasty, Karen A.

AU - Enghild, Jan J.

AU - Mast, Alan E.

PY - 2002/10/15

Y1 - 2002/10/15

N2 - Vascular injury results in the activation of coagulation and the release of proteolytic enzymes from neutrophils and connective-tissue cells, High concentrations of these inflammatory proteinases may destroy blood coagulation proteins, contributing to coagulation and bleeding disorders associated with severe inflammation. Matrix metalloproteinase-8 (MMP-8) is released from neutrophils at sites of inflammation and vascular disease. We have investigated the effect of MMP-8 degradation on the anticoagulant function of tissue factor pathway inhibitor (TFPI) as a potential pathological mechanism contributing to coagulation disorders. MMP-8 cleaves TFPI following Ser174 within the connecting region between the second and third Kunitz domains (kcat/Km ∼ 75 M-1 · s-1) as well as following Lys20 within the NH2-terminal region. MMP-8 cleavage of TFPI decreases the anticoagulant activity of TFPI in factor Xa initiated clotting assays as well as the ability of TFPI to inhibit factor Xa in amidolytic assays. Yet, MMP-8 cleavage does not alter the ability of TFPI to inhibit trypsin. Since the inhibition of both factor Xa and trypsin is mediated by binding to the second Kunitz domain, these results suggest that regions of TFPI other than the second Kunitz domain may directly interact with factor Xa. 125I-factor Xa ligand blots of TFPI fragments generated following MMP-8 degradation were used for probing binding interactions between factor Xa and regions of TFPI, other than the second Kunitz domain. In experiments performed under reducing conditions that disrupt the Kunitz domain structure, 125I-factor Xa binds to the C-terminal fragment of MMP-8-degraded TFPI. This fragment contains portions of TFPI distal to Ser174. which include the third Kunitz domain and the basic C-terminal region. An altered form of TFPI lacking the third Kunitz domain, but containing the C-terminal region, was used to demonstrate that the C-terminal region directly interacts with factor Xa.

AB - Vascular injury results in the activation of coagulation and the release of proteolytic enzymes from neutrophils and connective-tissue cells, High concentrations of these inflammatory proteinases may destroy blood coagulation proteins, contributing to coagulation and bleeding disorders associated with severe inflammation. Matrix metalloproteinase-8 (MMP-8) is released from neutrophils at sites of inflammation and vascular disease. We have investigated the effect of MMP-8 degradation on the anticoagulant function of tissue factor pathway inhibitor (TFPI) as a potential pathological mechanism contributing to coagulation disorders. MMP-8 cleaves TFPI following Ser174 within the connecting region between the second and third Kunitz domains (kcat/Km ∼ 75 M-1 · s-1) as well as following Lys20 within the NH2-terminal region. MMP-8 cleavage of TFPI decreases the anticoagulant activity of TFPI in factor Xa initiated clotting assays as well as the ability of TFPI to inhibit factor Xa in amidolytic assays. Yet, MMP-8 cleavage does not alter the ability of TFPI to inhibit trypsin. Since the inhibition of both factor Xa and trypsin is mediated by binding to the second Kunitz domain, these results suggest that regions of TFPI other than the second Kunitz domain may directly interact with factor Xa. 125I-factor Xa ligand blots of TFPI fragments generated following MMP-8 degradation were used for probing binding interactions between factor Xa and regions of TFPI, other than the second Kunitz domain. In experiments performed under reducing conditions that disrupt the Kunitz domain structure, 125I-factor Xa binds to the C-terminal fragment of MMP-8-degraded TFPI. This fragment contains portions of TFPI distal to Ser174. which include the third Kunitz domain and the basic C-terminal region. An altered form of TFPI lacking the third Kunitz domain, but containing the C-terminal region, was used to demonstrate that the C-terminal region directly interacts with factor Xa.

KW - Blood coagulation

KW - Neutrophil collagenase

KW - Proteolysis

UR - http://www.scopus.com/inward/record.url?scp=0037108733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037108733&partnerID=8YFLogxK

U2 - 10.1042/BJ20020696

DO - 10.1042/BJ20020696

M3 - Article

C2 - 12117418

AN - SCOPUS:0037108733

VL - 367

SP - 451

EP - 458

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 2

ER -